Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG AAPL NFLX AMZN BIIB IBB WYNN TSLA ALXN CELG JAZZ ILMN CHTR AMGN COST FFIV SSYS GMCR Z
Nyse: V PXD ACT IBM UNP IVV LNKD MCK SPG LMT GS CMI MMM FDX TWC AGN CXO BA CVX XEC
New Highs: CLR AGN CXO KMB HP EQT CAT VNO SLB SRE NEE RRC EMN HES PEP DOV DTE WLL COP FANG

The Hot Industries

Independent Oil & Gas 5
Oil & Gas Drilling & Exploration 3
Diversified Machinery 2

The Hot Sectors

Basic Materials 11
Utilities 3
Industrial Goods 2

AMRN Stock Chart


AMRN
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Other
Weekly

Employees:

185
Monthly

Website:

http://www.amarincorp.com

AMRN Amarin Corporation plc

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

favicon

Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May

11 Apr 2014, 10:24 amAmarin Corp. PLC (NASDAQ:AMRN) stock volume was tepid Apr. 10, with just 1,595,690 shares, a third of its three-month average volume of 4,405,235 shares.
favicon

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog

9 Apr 2014, 11:50 amBiotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
favicon

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns

9 Apr 2014, 9:48 amLast week saw a couple of positive FDA panel votes as well as some disappointing data on experimental drugs.
favicon

Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines

31 Mar 2014, 11:15 pmAdherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines
favicon

Amarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules

31 Mar 2014, 3:30 pmAmarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules
favicon

3 Biotech Stocks Under $10 to Trade for Breakouts

28 Mar 2014, 1:08 pmKeep these under-$10 biotech stocks on your radar. Click to view a price quote on ADMP . Click to research the Drugs industry.        
favicon

Northwest vs Feuerstein rhubarb round 3

28 Mar 2014, 11:42 amNorthwest Biotherapeutics ( NWBO -9.9% ) takes predictable exception to The Street's Adam Feuerstein regarding his bearish comments after CEO Linda Powers' DC-Vax presentation on March 27. The company insists that the statistical significance of the phase 3 trial results increases its chances of success not decreases as Mr. Feuerstein asserts. It also disputes his opinion that the trial has been ...
favicon

Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health

28 Mar 2014, 10:42 amLONDON, March 28, 2014 /PRNewswire/ -- On Thursday, March 27, 2014, the NASDAQ Composite ended at 4,151.23, down 0.54%, the Dow Jones Industrial Average edged 0.03% lower to 16,264.23, and the S&P 500 closed at 1,849.04, down 0.19%. The losses were broad based with seven out of ten...
favicon

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

21 Mar 2014, 2:22 pmBiotech columnist Adam Feuerstein answers readers' questions about health care companies. Click to view a price quote on AMRN . Click to research the Drugs industry.